Roche Holding AG

RO

Company Profile

  • Business description

    Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.

  • Contact

    Grenzacherstrasse 124
    Basel4070
    CHE

    T: +41 616881111

    E: [email protected]

    https://www.roche.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2025

    Employees

    103,249

Roche Holding AG News & Analysis

stocks

6 undervalued stocks with low beta

Berkshire Hathaway and Verizon are among the low-volatility stocks that trade at a discount.
stocks

An undervalued, wide-moat name in healthcare

Companies racing for a coronavirus cure have moved to lofty valuations. Morningstar analyst Alex Morozov is looking for lesser-known healthcare names.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,874.2025.800.29%
CAC 408,111.865.700.07%
DAX 4024,123.7946.920.19%
Dow JONES (US)48,114.26302.30-0.62%
FTSE 1009,829.15144.361.49%
HKSE25,468.78233.370.92%
NASDAQ23,111.4654.050.23%
Nikkei 22549,512.28128.990.26%
NZX 50 Index13,295.91129.04-0.96%
S&P 5006,800.2616.25-0.24%
S&P/ASX 2008,585.2021.600.25%
SSE Composite Index3,870.2845.471.19%

Market Movers